Literature DB >> 15461097

Systematic analysis of stutter percentages and allele peak height and peak area ratios at heterozygous STR loci for forensic casework and database samples.

Benoît Leclair1, Chantal J Frégeau, Kathy L Bowen, Ron M Fourney.   

Abstract

To assist the interpretation of STR DNA typing results from forensic casework samples containing mixtures, the range of heterozygous allele peak height and peak area ratios (HR) and stutter percentages (stutter %) for the loci comprised in the AmpFlSTR Profiler Plus (PP) kit were assessed on 468 database and 275 casework single source samples. Stutter % medians were similar for database and casework samples, ranging from 2% to 7%. The upper limit of the stutter value range was 16%, calculated as median +3 SD, although lower locus-specific values could be used. HR medians were 93 +/- 6.5% for database samples, 88 +/- 12% for casework samples. For casework samples, the maximum signal imbalance noted was 52%, calculated as median -3 SD. No significant difference was observed between peak height and peak area calculated values. This study shows the importance of selecting the proper reference database for the establishment of HR threshold values.

Entities:  

Mesh:

Year:  2004        PMID: 15461097

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  12 in total

1.  Systematic analysis of interference due to stutter in estimating chimerism following hematopoietic cell transplantation.

Authors:  Bharat Thyagarajan; Shawn Young; Stacy Floodman; Randolph Peterson; Xinjing Wang
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Magnitude-dependent variation in peak height balance at heterozygous STR loci.

Authors:  Jason R Gilder; Keith Inman; William Shields; Dan E Krane
Journal:  Int J Legal Med       Date:  2010-02-10       Impact factor: 2.686

3.  Evaluation of reliability on STR typing at leukemic patients used for forensic purposes.

Authors:  G Filoglu; O Bulbul; G Rayimoglu; F E Yediay; T Zorlu; S Ongoren; H Altuncul
Journal:  Mol Biol Rep       Date:  2014-02-22       Impact factor: 2.316

4.  Reduced reaction volumes and increased Taq DNA polymerase concentration improve STR profiling outcomes from a real-world low template DNA source: telogen hairs.

Authors:  Dennis McNevin; Janette Edson; James Robertson; Jeremy J Austin
Journal:  Forensic Sci Med Pathol       Date:  2015-05-22       Impact factor: 2.007

5.  Developmental validation of the HomyGene19+14Y System.

Authors:  Weian Du; Ling Chen; Hong Liu; Pingming Qiu; Fayuan Li; Jing Gao; Yu Zhou; Bangchao Wang; Chao Liu
Journal:  Int J Legal Med       Date:  2016-12-01       Impact factor: 2.686

6.  Utility of amplification enhancers in low copy number DNA analysis.

Authors:  Pamela L Marshall; Jonathan L King; Bruce Budowle
Journal:  Int J Legal Med       Date:  2014-05-22       Impact factor: 2.686

7.  Forensic trace DNA: a review.

Authors:  Roland Ah van Oorschot; Kaye N Ballantyne; R John Mitchell
Journal:  Investig Genet       Date:  2010-12-01

8.  A technique for setting analytical thresholds in massively parallel sequencing-based forensic DNA analysis.

Authors:  Brian Young; Jonathan L King; Bruce Budowle; Luigi Armogida
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

9.  A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis.

Authors:  Greggory S LaBerge; Eric Duvall; Zachary Grasmick; Kay Haedicke; John Pawelek
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

10.  A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer.

Authors:  Rossitza Lazova; Greggory S Laberge; Eric Duvall; Nicole Spoelstra; Vincent Klump; Mario Sznol; Dennis Cooper; Richard A Spritz; Joseph T Chang; John M Pawelek
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.